Emily Field
Stock Analyst at Barclays
(2.85)
# 2,678
Out of 4,408 analysts
818
Total ratings
44.8%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,129.35 | +23.97% | 16 | Jun 15, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $26.00 | -3.85% | 5 | Jun 15, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $221.59 | +24.10% | 8 | Jun 12, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $75 | $56.24 | +33.36% | 6 | Jun 2, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $114.90 | +21.85% | 8 | Jun 1, 2026 | |
| BIIB Biogen | Reiterated: Hold | $185 | $198.64 | -6.87% | 5 | May 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $350 | $350.53 | -0.15% | 6 | May 5, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $155 | $124.30 | +24.70% | 3 | Apr 21, 2026 | |
| CYTK Cytokinetics | Rated: Buy | $95 | $71.38 | +33.09% | 7 | Apr 6, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $52.23 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $151.56 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.80 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $51.01 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | $326.10 | -15.67% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | $1,958.00 | -25.94% | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | $75.54 | +39.00% | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | $67.02 | -17.93% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | $287.70 | +30.34% | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | $13,200.00 | +6.06% | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | $25.08 | -12.28% | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | $120.22 | -25.14% | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | $36.31 | -31.15% | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | $1,467.00 | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | $1,616.00 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | $132.70 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | $757.80 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | $9.09 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | $156.20 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | $260.20 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 → $125 | $28.66 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52.63 | $16.62 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.00001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.62 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
Jun 15, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,129.35
Upside: +23.97%
Pfizer
Jun 15, 2026
Maintained: Sell
Price Target: $25
Current: $26.00
Upside: -3.85%
AbbVie
Jun 12, 2026
Maintained: Buy
Price Target: $275
Current: $221.59
Upside: +24.10%
Bristol-Myers Squibb Company
Jun 2, 2026
Maintained: Buy
Price Target: $75
Current: $56.24
Upside: +33.36%
Merck & Co.
Jun 1, 2026
Maintained: Buy
Price Target: $140
Current: $114.90
Upside: +21.85%
Biogen
May 14, 2026
Reiterated: Hold
Price Target: $185
Current: $198.64
Upside: -6.87%
Amgen
May 5, 2026
Maintained: Hold
Price Target: $350
Current: $350.53
Upside: -0.15%
Gilead Sciences
Apr 21, 2026
Maintained: Hold
Price Target: $155
Current: $124.30
Upside: +24.70%
Cytokinetics
Apr 6, 2026
Rated: Buy
Price Target: $95
Current: $71.38
Upside: +33.09%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $52.23
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $151.56
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.80
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $51.01
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $326.10
Upside: -15.67%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: $1,958.00
Upside: -25.94%
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: $75.54
Upside: +39.00%
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: $67.02
Upside: -17.93%
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: $287.70
Upside: +30.34%
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: $13,200.00
Upside: +6.06%
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: $25.08
Upside: -12.28%
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: $120.22
Upside: -25.14%
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: $36.31
Upside: -31.15%
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: $1,467.00
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: $1,616.00
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: $132.70
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: $757.80
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: $9.09
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: $156.20
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: $260.20
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $145 → $125
Current: $28.66
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $52.63
Current: $16.62
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.00001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: $34
Current: $7.62
Upside: n/a